GLP-1s to pressure packaged food and beverage demand
The thesis presented: GLP-1 weight-loss drugs are expected to meaningfully reduce food and beverage consumption, creating a multi-year headwind for packaged food companies.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.